NIP
PBH icon

Nicholas Investment Partners’s Prestige Consumer Healthcare PBH Stock Holding History

Nicholas Investment Partners’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-49,385
Closed -$2.46M – 191
2022
Q3 		$2.46M Buy
+49,385
New +$2.73M 0.23% 112

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nicholas Investment Partners's PBH Position: Q4 2022 in Review

Nicholas Investment Partners sold out of Prestige Consumer Healthcare (PBH) in Q4 2022, closing a stake of 49,385 shares — an estimated $2.46M sold.

Nicholas Investment Partners first reported a position in PBH in Q3 2022 and held it in 1 quarter. The position peaked at $2.46M in Q3 2022. 289 funds tracked by Wall St. Rank hold PBH as of Q4 2022.

  • Nicholas Investment Partners reported no remaining Prestige Consumer Healthcare position as of Q4 2022 after selling out during the quarter.
  • Nicholas Investment Partners sold 49,385 Prestige Consumer Healthcare shares in Q4 2022, an estimated $2.46M.
  • Nicholas Investment Partners first reported a position in Prestige Consumer Healthcare in Q3 2022 and held it in 1 quarter.
  • Nicholas Investment Partners's Prestige Consumer Healthcare position peaked at $2.46M in Q3 2022.
  • 289 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2022.

Based on Nicholas Investment Partners's 13F filing for Q4 2022, filed 10 Feb 2023.